TCT-85 Efficacy And Safety Of Percutaneous Patent Foramen Ovale Closure In Patients With A Hypercoagulable Disorder
Jesús Herrero‐Garibi(Hospital Universitario de Burgos), Igor F. Palacios(Massachusetts General Hospital), Ferdinando Bounanno(Massachusetts General Hospital), Ignacio Cruz‐González(Instituto de Investigación Biomédica de Salamanca), Francisco Martín‐Herrero(Universidad de Salamanca), Pablo Rengifo(Massachusetts General Hospital), María Sánchez Ledesma(Complejo Hospitalario de Salamanca)
Cited by 0
Related Papers
Frailty in Older Adults Undergoing Aortic Valve Replacement
|Journal of the American College of Cardiology|2017|785
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
|European Heart Journal|2017|295
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology
|Circulation Arrhythmia and Electrophysiology|2019|286
Treatment of Higher-Risk Patients With an Indication for Revascularization
|Circulation|2016|247
Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy A report from then national heart, lung, and blood institute balloon valvuloplasty registry
|Journal of the American College of Cardiology|1996|145